Fmr LLC Supernus Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 8,404 shares of SUPN stock, worth $266,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,404

Previous 7,995 5.12%

Holding current value

$266,574

Previous $272,000 17.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.99 - $33.85 $10,629 - $13,844	409 Added 5.12%	8,404 $224,000
Q1 2024 May 13, 2024	BUY	$27.11 - $35.17 $2,982 - $3,868	110 Added 1.4%	7,995 $272,000
Q4 2023 Feb 13, 2024	BUY	$22.72 - $29.68 $3,930 - $5,134	173 Added 2.24%	7,885 $228,000
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $235,392 - $280,985	-8,538 Reduced 52.54%	7,712 $212,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $19,471 - $25,213	-651 Reduced 3.85%	16,250 $488,000
Q1 2023 May 11, 2023	BUY	$34.93 - $42.03 $289,115 - $347,882	8,277 Added 95.98%	16,901 $612,000
Q4 2022 Feb 13, 2023	SELL	$31.09 - $37.88 $875,960 - $1.07 Million	-28,175 Reduced 76.56%	8,624 $307,000
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $14,942 - $18,377	519 Added 1.43%	36,799 $1.25 Million
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $157,780 - $213,343	-6,229 Reduced 14.65%	36,280 $1.05 Million
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $6.03 Million - $6.95 Million	-211,392 Reduced 83.26%	42,509 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$26.37 - $34.22 $1.33 Million - $1.73 Million	-50,512 Reduced 16.59%	253,901 $7.4 Million
Q3 2021 Nov 15, 2021	SELL	$23.54 - $31.39 $22 Million - $29.4 Million	-935,682 Reduced 75.45%	304,413 $8.12 Million
Q2 2021 Aug 13, 2021	BUY	$26.72 - $33.19 $33.1 Million - $41.2 Million	1,240,095 New	1,240,095 $38.2 Million

Others Institutions Holding SUPN

# of Institutions

255

Shares Held

59.2M

Call Options Held

47.9K

Put Options Held

13.1K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.7B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account